Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)

NCT04384926 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT04384926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04384926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)
Lead sponsor
University of Birmingham
Phase
Observational
Overall status
Unknown status
Start date
March 30, 2020
Completion date
December 31, 2020
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, coronavirus, covid-19, surgery